SUGAR LAND, TX / ACCESSWIRE / July 2, 2020 / Neutra Corp. (OTC PINK:NTRR) retail subsidiary VIVIS is introducing three new products into the CBD marketplace. One is a Hemp Derived Broad Spectrum CBD Tincture which comes in 7 flavors and 3 dosage strengths, another is a Hemp Broad Spectrum CBD Lotion, and third is a Hemp Derived Broad Spectrum CBD Salve.
“These new products are a direct result of the expand capacity we gained from our new manufacturing facility,” said Neutra CEO Sydney Jim. “With greater capacity, we’ll be able to increase production of what we already make plus roll out new hemp-based goods to meet the public’s growing demand for high-quality VIVIS-brand products. The tinctures, lotion, and salves are the first in what will be a steady stream as we continue to build and expand the already respected VIVIS brand.”
VIVIS products are known for their third party lab-tested quality. Customers know that when they purchase a VIVIS product, its potency and purity are assured. Visit the company’s website at http://viviscbd.com
Thanks to its new manufacturing facility, VIVIS can now produce compliant, full-spectrum distillate, broad-spectrum distillate, 99%+ crystalline cannabidiol (Isolate). The company is also able to make a wider range of end-user CBD products than before, such as tinctures, gummies, lotions, salves, etc.
Many industry watchers are predicting the hemp-based CBD market will increase an annual average of 107 percent and shortly reach a size of $22 billion in the U.S.
About Neutra Corp.
Neutra Corp. (NTRR) is an early-stage research and development company with a focus on bringing modern healthy living solutions to a multibillion-dollar market. Cutting-edge technologies within the nutraceuticals, food and drug, and environmental purification sectors are creating a new kind of world culture-one where in which consumers are demanding access to products that promote health and stave off potential health dangers. One of the nutraceutical sub-markets is the new thriving hemp-based CBD market, in which the Company intends to participate. For more information, visit the Company’s website at http://www.NeutraInc.com.
NOTICE REGARDING FORWARD LOOKING STATEMENT
Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This news release contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements that include the words “believes,” “expects,” “anticipate” or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the company to differ materially from those expressed or implied by such forward-looking statements.
Neutra Contact:
Sydney Jim
888-433-4033
info@neutrainc.com
SOURCE: Neutra Corp
View source version on accesswire.com:
https://www.accesswire.com/596116/With-Manufacturing-Facility-Open-Neutra-Subsidiary-Rolls-Out-Multiple-New-Zero-THC-Products
GENEVA, SWITZERLAND / ACCESSWIRE / December 27, 2024 / RELIEF THERAPEUTICS Holding SA(SIX:RLF)(OTCQB:RLFTF)(OTCQB:RLFTY) (Relief, or…
The Role of Physiotherapy in Athletic Performance DUBAI, UAE / ACCESSWIRE / December 26, 2024…
CHICAGO, IL / ACCESSWIRE / December 26, 2024 / Cosmos Health Inc. ("Cosmos Health" or…
The CDC estimates that each year, about 385,000 healthcare workers in the United States suffer…
Research highlights how nutrition tracking drives success for weight loss and health goals NEW YORK,…
Coeptis Aims to Bring AI Innovation in Biotechnology and Technology WEXFORD, Pa., Dec. 26, 2024…